Navigation Links
Ovarian Cancer Prognosis May Depend on Gene Mutations
Date:4/4/2011

MONDAY, April 4 (HealthDay News) -- Ovarian cancer patients with the BRCA2 gene mutation are more likely to survive than those with the BRCA1 mutation or patients without either mutation, a new study finds.

U.S. researchers analyzed 3,531 cases of epithelial ovarian cancer, including 1,178 patients with BRCA1 mutations, 367 with BRCA2 mutations and 1,986 with neither mutation.

Five-year survival rates were 61 percent for those with the BRCA2 mutation, 46 percent for those with the BRCA1 mutation and 36 percent for those with neither mutation, the investigators found.

The study is to be presented Monday at the annual meeting of the American Association for Cancer Research, in Orlando, Fla. The research is considered preliminary until it is published in a peer-reviewed journal.

"There was some previous evidence that women with ovarian cancer who have mutations in the BRCA genes show improved survival compared to non-mutation carriers. Our study clearly shows that this survival difference is real. We also provide the first solid evidence that BRCA1 and BRCA2 mutations don't have the same impact on ovarian cancer survival," Kelly Bolton, a fellow at the U.S. National Cancer Institute, said in an AACR news release.

Further research is needed to find out why BRCA2 mutations are associated with better survival than BRCA1 mutations or no mutations. The mutations may affect a patient's response to chemotherapy, Bolton suggested.

About 1 in 400 to 1 in 800 women are born with either the BRCA1 or BRCA2 mutations, which increase the risk of ovarian and breast cancer. About 5 percent of ovarian cancer patients have BRCA1 or BRCA2 mutations.

More information

The American Cancer Society has more about ovarian cancer.

-- Robert Preidt

SOURCE: American Association for Cancer Research, news release, April 4, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Philanthropic pledge triples funds for TGen ovarian cancer research
2. Ohio State study: Targeted ovarian cancer therapy not cost-effective
3. GPs take more than a month to record ovarian cancer diagnosis in one in 10 cases
4. Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
5. New clinical trial to determine ovarian cancer risks in African-American women
6. Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
7. UH biochemist works to revolutionize ovarian cancer treatment
8. Ovarian cancer advances when genes are silenced
9. Few Lives Saved by Ovarian Cancer Screening: Study
10. Biological diversity of ovarian cancer lessens value of screening
11. Researchers map the way to personalised treatment for ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ovarian Cancer Prognosis May Depend on Gene Mutations
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges on regular brushing ... achieve optimal results. This important necessity inspired an inventor from Las Vegas, Nev., to ... ensure that people break or avoid bad techniques of brushing the teeth in order ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine ... San Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in ... and beyond the standard of care, demonstrating leadership within the MPN community and/or a ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announces the launch of its 60-day free trial program for all of the ... make the offer a truly hassle free experience. , FlexiSpot’s unique desktop risers ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... highly innovative, personalized cell-based treatment for a high-risk form of the most ... Children,s Hospital of Philadelphia today reported new results ... The physician-scientists presented findings at the annual meeting of the ... Continue Reading ... ...
(Date:12/2/2016)... 2, 2016 bioLytical Laboratories, un líder mundial en test ... INSTI HIV Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... Share, Development, Growth and Demand Forecast to 2022" report to their ... , , ... $6 billion in 2015, and it is expected to grow at a ... is expected to witness faster growth during the forecast period, a CAGR ...
Breaking Medicine Technology: